Regentis Biomaterials Ltd.

US$1.19As of Sun 8 Nov 2026, 12:00 UTC
AMEX:RGNTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Medical Instruments & Supplies
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$8.358M
ROIC (168.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.47
23.40%
(16.29%)
Hold 5|5|8|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.04
24.60%
22.41%
20.53%
36.77%
Revenue$M
0.672
0.656
0.657
0.646
3.02%
(0.63%)
(5.50%)
(6.18%)
Peers (US$8.358M)
Cap (US$)
PE
26.18M
12.10x
7.188M
—
Capital
TTM
5Y
10Y
Leveragex
1.600
0.217
0.202
EBIT/Intx
0.138
0.069
0.057
Own earn%
(0.35)
(33.44)
(31.07)
Sh yield%
36.44
36.50
38.05
Owners
Insiders/Inst%
9.11
41.88
Short interest%
3.68
SBC / revenue%
2.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
25–30
$1 testx
—
Incr. ROIC%
7